ONC

BeiGene
D

ONC

Arincen62/100B

BeiGene earnings

BeiGene reports its Q4 FY2026 results on 31 March 2027, before the market opens. Analysts expect earnings per share of 2.58 USD and revenue of 1.88B USD.

In Q3 FY2026, reported on 5 November 2026, BeiGene earned 4.59 USD a share against the 2.34 USD analysts expected (+96.2%), on revenue of 1.89B USD against 1.75B USD (+7.7%).

Last EPS surprise
+96.2%
Last revenue surprise
+7.7%
Move after the last report
+2.5%
Average move after earnings
2.5%

EPS and revenue against estimates

Next earnings · Q4 FY2026
EPS estimate
3.32 USD
Revenue estimate
1.88B USD
Last quarter · Q3 FY2026
EPS4.59Beat +96.2%Revenue1.89BBeat +7.7%

Revenue

ReportedEstimate

EPS

ReportedEstimate
PeriodReport dateEPS estimateReported EPSSurpriseEPS growthRevenue estimateReported revenueSurpriseRevenue growthNext-day move
Q1 FY20272.09——+6.84%1.76B——+16.56%—
Q4 FY20262.58——+344.83%1.88B——+25.38%—
Q4 FY20263.32——+472.41%1.88B——+25.38%—
Q3 FY20262.344.59+96.15%+321.10%1.75B1.89B+7.69%+33.81%+2.5%
Q2 FY20261.632.05+25.77%+144.05%1.62B1.71B+4.95%+29.63%+1.3%
Q1 FY20260.731.96+168.49%+60.66%1.44B1.51B+5.35%+35.46%+5.3%
Q4 FY20251.600.58-63.75%—1.47B1.50B+2.24%+32.84%-8.4%
Q3 FY20250.721.09+51.39%—1.45B1.41B-2.72%+41.00%+3.4%
Q2 FY20250.480.84+75.00%—1.44B1.32B-8.82%+41.56%-2.8%
Q1 FY2025-0.711.22+271.83%—1.25B1.12B-10.36%—-3.4%
Q4 FY2024-0.88-1.43-62.50%—1.04B1.13B+8.53%+77.78%+7.2%
Q3 FY2024-0.88-1.15-30.68%-157.21%—1.00B—+28.20%-5.8%
Q2 FY2024-2.10-1.15+45.24%——929.17M—+56.09%+3.3%
Q4 FY2023—-2.41———751.65M—+97.75%+1.7%
Q4 FY2023—-25.53———634.41M—+66.91%—
Q3 FY2023—2.01———781.31M—+101.56%—
Q2 FY2023—-3.64———595.26M—+74.27%—
Q4 FY2022—-3.34———447.80M—+109.27%—
Q4 FY2022—-30.54———380.10M—+77.63%—
Q3 FY2022—-5.39———387.63M—+87.77%-1.4%
Q2 FY2022—-5.56———341.57M—+127.73%-0.1%
Q4 FY2021—-4.24———306.63M—+206.32%-8.4%
Q4 FY2021—-6.16———213.98M—+113.77%-1.1%
Q3 FY2021—-4.46———206.44M—+126.66%+0.3%
Q2 FY2021—-5.23———149.99M—+128.52%+1.9%
Q4 FY2020—0.69———605.87M—+964.95%+4.3%
Q4 FY2020—-5.20———100.10M—+75.95%+1.4%
Q3 FY2020—-4.81———91.08M—+81.65%+1.8%
Q2 FY2020—-4.31———65.64M—-73.03%-0.3%
Q4 FY2019—-4.70———52.06M—-11.27%-1.6%
Q4 FY2019—-6.39———56.89M—-3.03%-0.5%
Q3 FY2019—-5.11———50.14M—-7.49%+0.4%
Q2 FY2019—-1.43———243.35M—+360.85%+2.6%
Q4 FY2018—-2.81———77.83M—+328.27%+4.9%
Q4 FY2018—-4.52———58.67M—+222.82%+2.4%
Q3 FY2018—-2.53—-199.65%—54.20M—-75.39%+1.9%
Q2 FY2018—-2.92———52.80M——+0.9%
Q4 FY2017—-2.03———32.54M——-1.6%
Q4 FY2017—-2.18———18.17M——+2.8%
Q3 FY2017—2.54———220.21M——-1.2%
Q2 FY2017—-1.52——————+0.4%
Q4 FY2016—-1.27——————+0.4%
Q4 FY2016—-0.95——————+1.4%
Q3 FY2016—-1.08——————+3.9%
Q2 FY2016—-0.73———393.00K—-71.52%-0.8%
Q4 FY2015—-0.68———677.00K—-50.98%+2.5%
Q4 FY2015—-0.86———4.68M—+238.67%—
Q3 FY2015—-0.26———1.38M—-78.76%—
Q2 FY2015—-0.10———1.38M—-46.49%—
Q4 FY2014—-0.19———1.38M—-46.53%—
Q4 FY2014—-0.07———1.38M—-46.45%—
Q3 FY2014—-0.18———6.50M———
Q2 FY2014—-4.26———2.58M———
Q4 FY2013—-4.26———2.58M———

The move is the shares' change on the trading day after the report: after a report after the close, the next day's close on the report day's; before the open, the report day's close on the day before's. Surprise is the reported figure against the analysts' average estimate.

Beat record

On average, analysts' EPS estimate was 89.1% off the result, either way, and their revenue estimate 6.3%, over the last 10 quarters.

EPS beats
7 / 10
Revenue beats
5 / 8
Average EPS surprise, last 10
+57.7%
Since
August 2024

See also:Forecast,EPS,Income statement

Common questions about BeiGene's earnings

Source: Financial Modeling Prep